We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOLS icon
1201
Evolus
EOLS
$406M
$2K ﹤0.01%
262
FTRE icon
1202
Fortrea Holdings
FTRE
$1.98B
$2K ﹤0.01%
328
IOVA icon
1203
Iovance Biotherapeutics
IOVA
$2.15B
$2K ﹤0.01%
1,006
-7,555
-88% -$18.8K
KALV
1204
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
154
KROS icon
1205
Keros Therapeutics
KROS
$198M
$2K ﹤0.01%
133
KURA icon
1206
Kura Oncology
KURA
$827M
$2K ﹤0.01%
297
MGTX icon
1207
MeiraGTx Holdings
MGTX
$1.1B
$2K ﹤0.01%
330
DFTX
1208
Definium Therapeutics
DFTX
$5.48B
$2K ﹤0.01%
242
PHAT icon
1209
Phathom Pharmaceuticals
PHAT
$934M
$2K ﹤0.01%
260
QURE icon
1210
uniQure
QURE
$2.47B
$2K ﹤0.01%
158
REPL icon
1211
Replimune Group
REPL
$521M
$2K ﹤0.01%
200
RLAY icon
1212
Relay Therapeutics
RLAY
$3.87B
$2K ﹤0.01%
486
SAGE
1213
DELISTED
Sage Therapeutics
SAGE
$2K ﹤0.01%
239
SANA icon
1214
Sana Biotechnology
SANA
$910M
$2K ﹤0.01%
767
SIGA icon
1215
SIGA Technologies
SIGA
$221M
$2K ﹤0.01%
270
SLDB icon
1216
Solid Biosciences
SLDB
$768M
$2K ﹤0.01%
400
STOK icon
1217
Stoke Therapeutics
STOK
$1.8B
$2K ﹤0.01%
175
TBPH icon
1218
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
215
TNGX icon
1219
Tango Therapeutics
TNGX
$4.24B
$2K ﹤0.01%
355
TRML
1220
DELISTED
Tourmaline Bio
TRML
$2K ﹤0.01%
95
TRVI icon
1221
Trevi Therapeutics
TRVI
$2.58B
$2K ﹤0.01%
305
TYRA icon
1222
Tyra Biosciences
TYRA
$1.81B
$2K ﹤0.01%
173
URGN icon
1223
UroGen Pharma
URGN
$2.01B
$2K ﹤0.01%
160
XERS icon
1224
Xeris Biopharma Holdings
XERS
$1.42B
$2K ﹤0.01%
404
XLP icon
1225
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$2K ﹤0.01%
20
+2
+11% +$162

Similar funds

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.